Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
Title:
Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
Author:
Le Calvé, Benjamin Rynkowski, Michal Le Mercier, Marie Bruyère, Céline Lonez, Caroline Gras, Thierry Haibe-Kains, Benjamin Bontempi, Gianluca Decaestecker, Christine Ruysschaert, Jean-Marie Kiss, Robert Lefranc, Florence